Categories: Political News

Blackstone Leads Race for $1.1–$1.3 Billion Buyout of EQT-Backed AGS Health

In a major development in the healthcare IT space, global private equity giant Blackstone has emerged as the frontrunner to acquire AGS Health, a leading revenue cycle management (RCM) services firm currently owned by EQT.

According to sources familiar with the matter, Blackstone is now the lead contender in the ongoing sale process, which could value AGS Health at around $1.1 to $1.3 billion. Binding bids were submitted last week, and while a final decision is yet to be made, Blackstone is said to have pulled ahead of other bidders after the latest round of evaluations.

“Post the submission of binding bids last week, Blackstone has edged ahead of other bidders and is now seen as the lead candidate to bag the deal. A final call is yet to be taken,” said one person aware of the developments.

Two other independent sources confirmed the same information to Moneycontrol. However, when approached for comments, EQT declined to respond, and Blackstone also did not reply to email queries sent by Moneycontrol at the time of publishing.

Strong Interest in RCM Sector

The proposed buyout comes at a time when the RCM (Revenue Cycle Management) segment is witnessing heightened M&A activity. AGS Health is considered one of the few remaining large-scale RCM assets currently available in the market, making it an attractive acquisition target for strategic and financial investors.

On April 24, Moneycontrol reported that multiple suitors — including Blackstone, Frazier Partners, and a TPG-General Atlantic consortium — had advanced to the next stage of due diligence. Earlier in February, it was revealed that EQT had appointed JP Morgan and Bank of America as sell-side advisors to oversee the transaction.

AGS Health has built a strong reputation in the RCM space and is likely to draw serious interest due to its scale, quality of clients, and market presence.

EQT’s Journey with AGS Health

EQT Private Capital Asia (formerly Baring Private Equity Asia) had acquired AGS Health back in 2019 for approximately $320 million. The potential buyout at $1.1–$1.3 billion marks a substantial value creation over a five-year period.

According to AGS Health’s LinkedIn profile, the firm employs around 13,000 RCM experts and serves over 150 healthcare customers, including nearly 50% of the top 20 hospitals in the United States and 40% of the 10 largest health systems in the country.

AGS Health has a significant presence in the US healthcare market, making it a strategic asset in the global RCM landscape.

A Hotbed of M&A Activity

The RCM sector has seen a flurry of high-value deals over the past year. Some notable transactions include:

  • EQT’s acquisition of ChrysCapital-owned GeBBS Healthcare for over $850 million

  • Access Healthcare’s majority stake sale to New Mountain Capital for approximately $2 billion

  • Omega Healthcare’s buyout by Ontario Teachers Pension Plan for around $1.8 billion

These deals reflect the growing demand for high-quality healthcare IT and RCM services, as global private equity players continue to place big bets on digital health infrastructure.

Sneha Gandhi

Sneha Gandhi is a passionate stock market learner and finance content writer who loves exploring market trends and sharing the latest updates with readers. She enjoys simplifying complex market news and making financial insights easy for everyone to understand.

Published by
Sneha Gandhi

Recent Posts

SpiceJet Gains Up to 14% as Market Reacts to IndiGo’s Large-Scale Flight Cancellations

SpiceJet Shares Soar as IndiGo’s Operational Crisis Shifts Investor Attention SpiceJet shares rallied sharply for…

34 minutes ago

IndiGo Falls 10% as New FDTL Norms Disrupt Operations and Lift Cost Estimates, Brokerages Note

IndiGo Shares Slide 10% as Mass Cancellations and Rising Costs Shake Investor Confidence IndiGo’s parent…

50 minutes ago

Corona Remedies IPO Day 1: Issue Subscribed 30% So Far; GMP Surges as Subscription Opens

The initial public offering (IPO) of Corona Remedies Ltd, a pharmaceutical company operating across multiple…

1 hour ago

Parliament Winter Session: 10-Hour Vande Mataram Debate Begins; PM Modi Says It Became Bengal’s “War Cry”

The Winter Session of Parliament is set for a politically charged week as Vande Mataram…

2 hours ago

Sensex Falls 350 Points, Nifty Slips Below 26,100 as Investors Turn Cautious Ahead of US Fed Meet

The Indian equity markets witnessed broad-based weakness on Monday, with benchmark indices Sensex and Nifty…

3 hours ago

Kaynes Tech Shares Crash 12% as JPMorgan Warns Against ‘Bottom Fishing’; Kotak Flags Disclosure Mismatches

Shares of Kaynes Technology India extended their sharp fall for the second straight session on…

3 hours ago

This website uses cookies.